Helen Frankenthaler Foundation

Palmitoyl Tripeptide-5

PalMitoyl Tripeptide-1 Acetate

PalMitoyl Tripeptide-1 Acetate

Catalog No. TP2186L

Cas No. 1628252-62-9

Alias PalMitoyl Tripeptide-1 Acetate(147732-56-7 Free base)

PalMitoyl Tripeptide-1 Acetate is a form of the extracellular matrix-derived peptide containing palmitic acid.

Product Details

PalMitoyl Tripeptide-1 Acetate is a form of the extracellular matrix-derived peptide containing palmitic acid.

Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mg$31In StockIn Stock
25 mg$54In StockIn Stock
50 mg$81In StockIn Stock
100 mg$120In StockIn Stock
200 mg$181-In Stock

In Stock Estimated shipping date USA Warehouse 1-2 days Global Warehouse 5-7 days

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

PalMitoyl Tripeptide-1 Acetate Common Questions

What’s Kd?

Dissociation consent (Kd) reflects the affinity of a compound for its target. In some cases, it can be equivalent to Ki.

Does the compound differ in any way when it is in the form of hydrochloride or sulfate ions? What is the difference between the salt form and the free form?

The molecules in salt and non-salt forms exhibit the same activity, and they have consistent effects in biological experiments. Their activity and usage are identical. The only difference lies in their salt forms, which may result in variations in physical properties such as solubility. It is recommended to choose based on solubility and experimental requirements.

What’s Ki?

Inhibitory consent (Ki) reflects the strength of inhibitor binding to the target, corresponding to the concentration of free inhibitor when 50% of the target is bound by the inhibitor.

What’s EC50?

Half maximal effective concentratioin(EC50) refers to the concentration of a compound that achieves 50% of the maximum effect(inhibitory/stimulatory effect),after a specified exposure duration.

What’s pIC50?

pIC50 is the negative log of the IC50 value when converted to molar.That is, pIC50=-log(IC50).

Select Batch

Purity:99.73%

Appearance:Solid

Color:White

Contact us for more batch information

Product Introduction

Bioactivity

Description PalMitoyl Tripeptide-1 Acetate is a form of the extracellular matrix-derived peptide containing palmitic acid.

Synonyms PalMitoyl Tripeptide-1 Acetate(147732-56-7 Free base)

Chemical Properties

Molecular Weight 638.84

Formula C 32 H 58 N 6 O 7

Cas No.1628252-62-9

Smiles NCCCC[C@@H](C(O)=O)NC([C@H](CC1=CNC=N1)NC(CNC(CCCCCCCCCCCCCCC)=O)=O)=O.CC(O)=O

Relative Density.no data available

Sequence palmitoyl-Gly-His-Lys-OH.CH3CO2H

Sequence Short GHK

Storage & Solubility Information

Storage keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator
  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method: For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH 2 O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline, PBS or ddH 2 O and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

Sci Citation

References

1.Lintner, K., and Peschard, O. Biologically active peptides: From a laboratory bench curiosity to a functional skin care product. Int. J. Cosmet. Sci. 22(3), 207-218 (2000).

2.Zhang, H., Sun, J., Xin, X., et al. Modulating self-assembly behavior of a salt-free peptide amphiphile (PA) and zwitterionic surfactant mixed system. J. Colloid. Interface Sci. 467, 43-50 (2016).

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Related Tags: buy PalMitoyl Tripeptide-1 Acetate | purchase PalMitoyl Tripeptide-1 Acetate | PalMitoyl Tripeptide-1 Acetate cost | order PalMitoyl Tripeptide-1 Acetate | PalMitoyl Tripeptide-1 Acetate chemical structure | PalMitoyl Tripeptide-1 Acetate formula | PalMitoyl Tripeptide-1 Acetate molecular weight

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, improve your experience, and analyze site usage.

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.